Ramucirumab (anti-VEGFR), CAS [[947687-13-0]]

Produktübersicht

• Artikelname: Ramucirumab (anti-VEGFR), CAS [[947687-13-0]]
• Artikelnummer: MCE-HY-P9920A
• Hersteller Artikelnummer: HY-P9920A
• Alternativnummer: MCE-HY-P9920A-10MG,MCE-HY-P9920A-25MG,MCE-HY-P9920A-50MG,MCE-HY-P9920A-5MG,MCE-HY-P9920A-1MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper

Produktbeschreibung

Ramucirumab (anti-VEGFR) is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab (anti-VEGFR) is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab (anti-VEGFR) is also an angiogenesis inhibitor[1][2].

Produkteigenschaften

• Molekulargewicht: (144.56 kDa)
• Reinheit: 99.9
• CAS Nummer: [947687-13-0]
• Target-Kategorie: VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies